Snake antivenom (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Snake antivenom" in English language version.

refsWebsite

Global rank English rank

9web.archive.org

1^st place

3handle.net

102^nd place

76^th place

3nih.gov

4^th place

2doi.org

2^nd place

1harvard.edu

18^th place

17^th place

1who.int

195^th place

302^nd place

1worldcat.org

5^th place

1smithsonianmag.com

503^rd place

364^th place

1pharmaceutical-technology.com

low place

1fda.gov

447^th place

338^th place

1orlandosentinel.com

530^th place

319^th place

1popularmechanics.com

1,808^th place

1,159^th place

1bioclon.com.mx

low place

1poisoncentertampa.org

low place

1clinicaltrials.gov

5,225^th place

4,062^nd place

bioclon.com.mx

"Our Products – Coralmyn". Bioclon.com.mx. Archived from the original on 13 October 2010. Retrieved 2010-11-16.

clinicaltrials.gov

"Emergency Treatment of Coral Snake Envenomation With Antivenom - Full Text View - ClinicalTrials.gov". National Institutes of Health. Archived from the original on 30 March 2016. Retrieved 19 March 2016.

doi.org

de la Rosa G, Olvera F, Archundia IG, Lomonte B, Alagón A, Corzo G (August 2019). "Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species". Nature Communications. 10 (1): 3642. Bibcode:2019NatCo..10.3642D. doi:10.1038/s41467-019-11639-2. PMC 6692343. PMID 31409779.
Sánchez EE, Galán JA, Perez JC, Rodríguez-Acosta A, Chase PB, Pérez JC (March 2003). "The efficacy of two antivenoms against the venom of North American snakes". Toxicon. 41 (3): 357–65. doi:10.1016/s0041-0101(02)00330-6. PMID 12565759.

fda.gov

"Safety & Availability (Biologics) > Expiration Date Extension for North American Coral Snake Antivenin (Micrurus fulvius) (Equine Origin) Lot 4030026 Through October 31, 2014". Food and Drug Administration. Archived from the original on 3 March 2016. Retrieved 19 March 2016.

handle.net

hdl.handle.net

Stuart MC, Kouimtzi M, Hill SR, eds. (2009). WHO Model Formulary 2008. World Health Organization. p. X. hdl:10665/44053. ISBN 9789241547659.
Organization, World Health (2019). World Health Organization model list of essential medicines (21st list 2019 ed.). Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
WHO Expert Committee on Biological Standardization (2017). "Annex 5; Guidelines for the production, control and regulation of snake antivenom immunoglobulins;Replacement of Annex 2 of WHO Technical Report Series, No. 964" (PDF). WHO Expert Committee on Biological Standardization, sixty-seventh report. Geneva, Switzerland: World Health Organization (WHO). pp. 197–388. hdl:10665/255657. ISBN 978-92-4-069645-7. ISSN 0512-3054. WHO technical report series;1004. License: CC BY-NC-SA 3.0 IGO. Archived (PDF) from the original on 2020-02-14. Retrieved 2020-01-20.

harvard.edu

ui.adsabs.harvard.edu

de la Rosa G, Olvera F, Archundia IG, Lomonte B, Alagón A, Corzo G (August 2019). "Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species". Nature Communications. 10 (1): 3642. Bibcode:2019NatCo..10.3642D. doi:10.1038/s41467-019-11639-2. PMC 6692343. PMID 31409779.

nih.gov

pubmed.ncbi.nlm.nih.gov

de la Rosa G, Olvera F, Archundia IG, Lomonte B, Alagón A, Corzo G (August 2019). "Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species". Nature Communications. 10 (1): 3642. Bibcode:2019NatCo..10.3642D. doi:10.1038/s41467-019-11639-2. PMC 6692343. PMID 31409779.
Sánchez EE, Galán JA, Perez JC, Rodríguez-Acosta A, Chase PB, Pérez JC (March 2003). "The efficacy of two antivenoms against the venom of North American snakes". Toxicon. 41 (3): 357–65. doi:10.1016/s0041-0101(02)00330-6. PMID 12565759.

ncbi.nlm.nih.gov

de la Rosa G, Olvera F, Archundia IG, Lomonte B, Alagón A, Corzo G (August 2019). "Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species". Nature Communications. 10 (1): 3642. Bibcode:2019NatCo..10.3642D. doi:10.1038/s41467-019-11639-2. PMC 6692343. PMID 31409779.

orlandosentinel.com

Breen, David (12 October 2013). "Risk from coral-snake bites grows as antivenin dwindles". Orlando Sentinel. Archived from the original on 24 May 2014. Retrieved 25 May 2014.

pharmaceutical-technology.com

"Antivenom Supply for Snake bites". www.pharmaceutical-technology.com. 24 April 2019. Archived from the original on 10 January 2021. Retrieved 25 July 2020.

poisoncentertampa.org

"Coral Snake Antivenom - Poison Center Tampa". Poison Center Tampa. Archived from the original on 1 April 2016. Retrieved 19 March 2016.

popularmechanics.com

"Antivenom Shortages – Cost of Antivenom Production Creates Shortages". Popular Mechanics. 2010-05-10. Archived from the original on 2010-05-13. Retrieved 2010-11-16.

smithsonianmag.com

Lewis, Danny (11 September 2015). "Why A Single Vial Of Antivenom Can Cost $14,000". Smithsonian. Archived from the original on 3 May 2019. Retrieved 9 January 2017.

web.archive.org

WHO Expert Committee on Biological Standardization (2017). "Annex 5; Guidelines for the production, control and regulation of snake antivenom immunoglobulins;Replacement of Annex 2 of WHO Technical Report Series, No. 964" (PDF). WHO Expert Committee on Biological Standardization, sixty-seventh report. Geneva, Switzerland: World Health Organization (WHO). pp. 197–388. hdl:10665/255657. ISBN 978-92-4-069645-7. ISSN 0512-3054. WHO technical report series;1004. License: CC BY-NC-SA 3.0 IGO. Archived (PDF) from the original on 2020-02-14. Retrieved 2020-01-20.
Lewis, Danny (11 September 2015). "Why A Single Vial Of Antivenom Can Cost $14,000". Smithsonian. Archived from the original on 3 May 2019. Retrieved 9 January 2017.
"Antivenom Supply for Snake bites". www.pharmaceutical-technology.com. 24 April 2019. Archived from the original on 10 January 2021. Retrieved 25 July 2020.
"Safety & Availability (Biologics) > Expiration Date Extension for North American Coral Snake Antivenin (Micrurus fulvius) (Equine Origin) Lot 4030026 Through October 31, 2014". Food and Drug Administration. Archived from the original on 3 March 2016. Retrieved 19 March 2016.
Breen, David (12 October 2013). "Risk from coral-snake bites grows as antivenin dwindles". Orlando Sentinel. Archived from the original on 24 May 2014. Retrieved 25 May 2014.
"Antivenom Shortages – Cost of Antivenom Production Creates Shortages". Popular Mechanics. 2010-05-10. Archived from the original on 2010-05-13. Retrieved 2010-11-16.
"Our Products – Coralmyn". Bioclon.com.mx. Archived from the original on 13 October 2010. Retrieved 2010-11-16.
"Coral Snake Antivenom - Poison Center Tampa". Poison Center Tampa. Archived from the original on 1 April 2016. Retrieved 19 March 2016.
"Emergency Treatment of Coral Snake Envenomation With Antivenom - Full Text View - ClinicalTrials.gov". National Institutes of Health. Archived from the original on 30 March 2016. Retrieved 19 March 2016.

who.int

WHO Expert Committee on Biological Standardization (2017). "Annex 5; Guidelines for the production, control and regulation of snake antivenom immunoglobulins;Replacement of Annex 2 of WHO Technical Report Series, No. 964" (PDF). WHO Expert Committee on Biological Standardization, sixty-seventh report. Geneva, Switzerland: World Health Organization (WHO). pp. 197–388. hdl:10665/255657. ISBN 978-92-4-069645-7. ISSN 0512-3054. WHO technical report series;1004. License: CC BY-NC-SA 3.0 IGO. Archived (PDF) from the original on 2020-02-14. Retrieved 2020-01-20.

worldcat.org

search.worldcat.org

WHO Expert Committee on Biological Standardization (2017). "Annex 5; Guidelines for the production, control and regulation of snake antivenom immunoglobulins;Replacement of Annex 2 of WHO Technical Report Series, No. 964" (PDF). WHO Expert Committee on Biological Standardization, sixty-seventh report. Geneva, Switzerland: World Health Organization (WHO). pp. 197–388. hdl:10665/255657. ISBN 978-92-4-069645-7. ISSN 0512-3054. WHO technical report series;1004. License: CC BY-NC-SA 3.0 IGO. Archived (PDF) from the original on 2020-02-14. Retrieved 2020-01-20.